While neutropenia rates were comparable between Candida and bacterial BSI cohorts, prior therapies, advanced disease, and significantly lower serum albumin levels indicated poorer functional status, malnutrition, frailty, and immune dysfunction as underlying risk factors for Candida BSI. This evidence concerns the gene ALB and nutritional deficiency disease.